Veterinary Device Market by Device Category, Offering, Animal Category, Portability Form Factor, Usage Pattern, End User, Distribution Channel

List of Tables

The Veterinary Device Market is projected to grow by USD 5.12 billion at a CAGR of 6.00% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 3.40 billion
Estimated Year [2026]	USD 3.60 billion
Forecast Year [2032]	USD 5.12 billion
CAGR (%)	6.00%

Veterinary Device Market Introduction

The veterinary device market is advancing as companion animal care, livestock health management, and preventive veterinary medicine converge around faster diagnostics, safer procedures, and better clinical monitoring. Demand is supported by documented increases in pet healthcare spending reported by the American Pet Products Association and by continued global emphasis on animal disease surveillance from organizations such as the World Organisation for Animal Health and the Food and Agriculture Organization.

Core product categories include veterinary diagnostic devices, imaging systems, surgical instruments, anesthesia equipment, patient monitoring devices, orthopedic implants, dental equipment, and wearable animal health technology. Buyers are prioritizing accuracy, workflow efficiency, durability, infection control, data connectivity, and regulatory compliance as clinics, hospitals, laboratories, shelters, universities, and farms modernize animal care delivery.

Transformative Shifts in the Veterinary Device Landscape

The veterinary device landscape is shifting from reactive treatment toward data-enabled, preventive animal health. Veterinary hospitals are adopting digital radiography, ultrasound, point-of-care analyzers, telehealth tools, electronic medical records, and connected monitoring to shorten diagnostic turnaround, improve case documentation, and support clinical decision-making.

At the same time, livestock producers are using sensors, imaging, reproductive technologies, automated weighing, and herd monitoring systems to improve productivity, detect disease earlier, and support antimicrobial stewardship. Regulatory scrutiny, cybersecurity requirements, sustainability expectations, and demand for evidence-based outcomes are raising performance expectations for manufacturers across the veterinary medical device value chain.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical layer across veterinary imaging, triage, pathology support, remote monitoring, and practice workflow automation. Peer-reviewed veterinary studies show AI can assist image interpretation, lesion detection, signal analysis, and pattern recognition when algorithms are validated against expert-reviewed datasets and used within defined clinical limits.

The cumulative impact is higher throughput, earlier anomaly detection, more consistent documentation, and improved decision support for busy veterinary teams. However, responsible adoption requires clinical oversight, representative training data, transparent performance metrics, privacy safeguards, cybersecurity controls, and integration with existing veterinary information systems to avoid workflow disruption or diagnostic overreliance.

Key Regional Insights

North America remains a leading demand center for veterinary devices because of high companion animal spending, advanced veterinary hospitals, specialty and emergency care networks, and broad adoption of diagnostic imaging, dental, surgical, anesthesia, and monitoring equipment. Europe benefits from mature animal welfare standards, strong veterinary education networks, established food safety systems, and increasing clinic consolidation, while the European Union's regulatory environment continues to influence quality, traceability, and post-market expectations for veterinary medical technologies.

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, and Australia invest in pet care infrastructure, livestock productivity, aquaculture health, and diagnostic capacity. Latin America is supported by Brazil and Mexico's large animal populations, production-animal sectors, and growing companion animal care demand. The Middle East is improving access to premium companion animal care, equine health services, and food security programs, while Africa's opportunity is tied to livestock health, mobile diagnostics, cold-chain improvement, and public-private disease surveillance programs aligned with transboundary animal disease control.

Key Group Insights

Within ASEAN, rising urban pet ownership, expanding veterinary clinic networks, and livestock modernization are increasing demand for affordable diagnostic, surgical, dental, and monitoring devices suited to varied infrastructure conditions. The GCC is investing in high-quality veterinary hospitals, equine care, falconry services, and food security programs, creating demand for premium imaging, laboratory, anesthesia, and biosecurity equipment.

The European Union emphasizes animal welfare, traceability, antimicrobial stewardship, and product quality, making it a key environment for compliant veterinary technologies and evidence-based adoption. BRICS economies provide scale across livestock, aquaculture, poultry, dairy, and companion animal care, though pricing, procurement models, and distribution maturity vary widely. G7 markets lead in advanced imaging, digital platforms, specialty care, and connected practice workflows, while NATO countries increasingly align procurement and infrastructure planning with higher standards for supply resilience, cybersecurity, emergency readiness, and critical service continuity.

Key Country Insights

The United States is a major opportunity for advanced veterinary devices, supported by high pet healthcare spending, specialty hospitals, reference diagnostics, and strong adoption of imaging, dental, anesthesia, surgical, and monitoring technologies. Canada shows steady demand for clinic equipment, companion animal diagnostics, and livestock health tools, while Mexico and Brazil combine companion animal growth with significant production-animal needs across cattle, poultry, swine, and animal disease surveillance.

The United Kingdom, Germany, France, Italy, and Spain are shaped by mature veterinary networks, higher welfare expectations, expanding pet insurance penetration, and continued investment in diagnostic and surgical capabilities. Russia remains focused on domestic supply, import substitution, and livestock health, particularly in food-animal production. China and India offer scale through pet ownership growth, urban veterinary service expansion, dairy and poultry productivity, and increasing demand for point-of-care diagnostics, while Japan, Australia, and South Korea show strong adoption of premium diagnostics, imaging, monitoring, dentistry, rehabilitation, and connected animal health solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed product claims, interoperability, clinical usability, service reliability, and clear economic value for veterinary practices. Devices that reduce procedure time, improve diagnostic confidence, enhance patient safety, support remote monitoring, or lower total cost of ownership are best positioned with veterinary hospitals, specialty centers, livestock operators, and large practice groups.

Manufacturers should strengthen post-market surveillance, user training, cybersecurity, software update governance, repair networks, and regional regulatory planning. Strategic partnerships with veterinary universities, reference laboratories, telehealth platforms, distributors, shelters, and livestock integrators can accelerate validation, clinical adoption, and reimbursement readiness where applicable. Leaders should also design tiered product portfolios to address premium specialty care, general practice affordability, and field-use durability in emerging regions.

Research Methodology

This executive summary is developed using secondary research from authoritative sources including veterinary associations, regulatory agencies, animal health organizations, public trade data, peer-reviewed journals, and regional economic indicators. Sources considered include guidance from veterinary regulatory authorities, World Organisation for Animal Health animal health data, Food and Agriculture Organization livestock statistics, Eurostat, OECD indicators, national veterinary bodies, and published research on veterinary diagnostics, imaging, monitoring, and artificial intelligence.

Insights are triangulated across demand indicators, installed-base trends, technology adoption patterns, regulatory signals, clinical workflow needs, and end-user purchasing behavior. Qualitative validation emphasizes product utility, diagnostic relevance, safety, usability, training requirements, service availability, and market access considerations across companion animal, equine, livestock, aquaculture, laboratory, shelter, and mixed-practice settings.

Conclusion

The veterinary device market is moving into a more connected, data-driven, and outcomes-oriented phase. Momentum is reinforced by pet humanization, livestock health priorities, clinic modernization, antimicrobial stewardship, zoonotic disease preparedness, and the need for faster, more reliable diagnostics across veterinary care settings.

Organizations that combine validated technology, practical workflows, regional compliance, cybersecurity, and strong customer support will be better positioned to capture demand. The most durable opportunities will come from veterinary devices that improve animal outcomes while supporting veterinarian productivity, clinical confidence, operational efficiency, and long-term care quality.

Product Code: MRR-034B500303A4

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Device Market, by Device Category

7.1. Diagnostic Devices
- 7.1.1. In-Clinic Analyzers
- 7.1.2. Rapid Test Systems
- 7.1.3. Examination & Visualization Devices
- 7.1.4. Sample Collection Devices
7.2. Imaging Systems
- 7.2.1. Radiography Systems
- 7.2.2. Ultrasound Systems
- 7.2.3. Computed Tomography Systems
- 7.2.4. Magnetic Resonance Imaging Systems
7.3. Surgical Devices
- 7.3.1. Electrosurgical Units
- 7.3.2. Surgical Lasers
- 7.3.3. Powered Surgical Instruments
- 7.3.4. Wound Closure Devices
7.4. Therapeutic Devices
- 7.4.1. Infusion & Fluid Delivery Pumps
- 7.4.2. Dialysis & Renal Support Devices
- 7.4.3. Laser Therapy Devices
- 7.4.4. Shockwave Therapy Devices
7.5. Monitoring Devices
7.6. Laboratory Equipment

8. Veterinary Device Market, by Offering

8.1. Equipment
- 8.1.1. Hardware Systems
- 8.1.2. Embedded Electronics & Sensors
- 8.1.3. Mechanical Assemblies
8.2. Accessories & Attachments
- 8.2.1. Probes & Transducers
- 8.2.2. Electrodes & Leads
- 8.2.3. Handpieces & Tips
8.3. Consumables & Disposables

9. Veterinary Device Market, by Animal Category

9.1. Companion Animals
- 9.1.1. Canine
- 9.1.2. Feline
- 9.1.3. Small Mammals
9.2. Livestock & Production Animals
- 9.2.1. Cattle
- 9.2.2. Swine
- 9.2.3. Poultry
- 9.2.4. Sheep & Goats
9.3. Equine
- 9.3.1. Horses
- 9.3.2. Donkeys & Mules
9.4. Exotic & Wildlife
9.5. Aquatic Animals

10. Veterinary Device Market, by Portability Form Factor

10.1. Stationary
10.2. Portable
10.3. Wearable
10.4. Implantable

11. Veterinary Device Market, by Usage Pattern

11.1. Reusable
11.2. Single-Use Disposable

12. Veterinary Device Market, by End User

12.1. Veterinary Clinics
- 12.1.1. Mobile Clinics
- 12.1.2. Small Clinics
12.2. Home Care Settings
12.3. Research Laboratories
12.4. Veterinary Hospitals
- 12.4.1. Specialty Hospitals
- 12.4.2. Teaching Hospitals

13. Veterinary Device Market, by Distribution Channel

13.1. Direct Sales
13.2. Distributors
13.3. Online Sales

14. Veterinary Device Market, by Region

14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa

15. Veterinary Device Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Veterinary Device Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
- 17.1.1. Concentration Ratio (CR)
- 17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025

18. Company Profiles

18.1. IDEXX Laboratories, Inc.
18.2. Zoetis Inc.
18.3. Mars, Incorporated
18.4. Covetrus, Inc.
18.5. GE Healthcare Technologies, Inc.
18.6. Fujifilm Holdings Corporation
18.7. Canon Medical Systems Corporation
18.8. Becton, Dickinson and Company
18.9. Carestream Health, Inc.
18.10. Bio-Rad Laboratories, Inc.
18.11. ICU Medical, Inc.
18.12. Agfa-Gevaert Group
18.13. Thermo Fisher Scientific Inc.
18.14. Esaote S.p.A.
18.15. bioMerieux S.A.
18.16. Neogen Corporation
18.17. Masimo Corporation
18.18. Nihon Kohden Corporation
18.19. B. Braun Vet Care GmbH
18.20. Bionet Co., Ltd.
18.21. Accesia AB
18.22. Dentalaire, International
18.23. IMEX Veterinary, Inc. by Vimian Group
18.24. Jorgensen Laboratories, LLC
18.25. Midmark Corporation
18.26. Mindray Bio-Medical Electronics Co., Ltd.
18.27. MinXray, Inc.
18.28. Nonin Medical, Inc.
18.29. Orthomed (UK) Ltd.